Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study

被引:0
作者
Junyu Lin
Ruwei Ou
Chunyu Li
Yanbing Hou
Lingyu Zhang
Qianqian Wei
Dejiang Pang
Kuncheng Liu
Qirui Jiang
Tianmi Yang
Yi Xiao
Bi Zhao
Xueping Chen
Wei Song
Jing Yang
Ying Wu
Huifang Shang
机构
[1] Sichuan University,Department of Neurology, West China Hospital
来源
BMC Medicine | / 21卷
关键词
Parkinson’s disease; Biomarkers; GFAP; Prospective cohort study; Disease progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 266 条
[1]  
An H(2021)Adenovirus-induced reactive astrogliosis exacerbates the pathology of Parkinson’s disease Exp Neurobiol. 30 222-31
[2]  
Lee H(2022)Astrocytes in neurodegeneration: inspiration from genetics Front Neurosci 16 882316-55
[3]  
Yang S(2022)Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease J Neural Transm (Vienna) 129 545-15
[4]  
Won W(2014)Enteric GFAP expression and phosphorylation in Parkinson’s disease J Neurochem 130 805-61
[5]  
Lee CJ(2019)Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study Lancet Neurol 18 953-6
[6]  
Nam MH(2021)Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation biomarker in acute ischemic stroke J Inflamm Res 14 7501-70
[7]  
Huang J(2017)GFAP in early multiple sclerosis: a biomarker for inflammation Neurosci Lett 657 166-72
[8]  
Li C(2022)Blood GFAP as an emerging biomarker in brain and spinal cord disorders Nat Rev Neurol 18 158-83
[9]  
Shang H(2021)Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum JAMA Neurol 78 1471-5
[10]  
Gschmack E(2012)Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson’s disease patients Clin Neurol Neurosurg 114 372-8